<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049722</url>
  </required_header>
  <id_info>
    <org_study_id>AVOPT</org_study_id>
    <nct_id>NCT03049722</nct_id>
  </id_info>
  <brief_title>Clinical Investigation Plan for the AVOPT Data Collection Clinical Study</brief_title>
  <official_title>Clinical Investigation Plan for the AVOPT Data Collection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik Canada Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik Canada Inc</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect clinical data for the development and evaluation of a
      new device feature for automatic AV-delay (AVD) optimization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation analysis between measured PWD and optimal AVD.</measure>
    <time_frame>Up to 6 hours</time_frame>
    <description>Data analysis will be performed on the collected data to relate P wave duration (PWD) measured from the far field IEGM to the optimal AVD determined from the hemodynamic assessment.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cardiac Pacemaker, Artificial</condition>
  <arm_group>
    <arm_group_label>AVOPT Patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker</intervention_name>
    <arm_group_label>AVOPT Patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients implanted with an Evia DR(T) or Entovis DR(T) pacemaker

          -  Possessing 1st or 3rd degree AV block

          -  Implanted with Biotronik bipolar RA and RV leads

          -  Implantation date should be at least 4 months prior to this study

        Exclusion Criteria:

          -  Patient is a minor (18 years old or younger)

          -  Patient is pregnant or breast-feeding

          -  Patient does not have the legal capacity to provide consent

          -  Patient has Mobitz type I or Mobitz type II heart block

          -  Patient has persistent supraventricular tachycardia (including atrial fibrillation) or
             ectopic beats.

          -  Patient is participating in other clinical studies during the clinical study

          -  Patient is strictly pacemaker dependent (physician discretion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rouge Valley Centenary</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <zip>M1E 4B9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUS - Centre hospitalier universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <last_update_submitted>February 9, 2017</last_update_submitted>
  <last_update_submitted_qc>February 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

